本页面由Tiger Trade Technology Pte. Ltd.提供服务

Beta Bionics, Inc.

17.86
+0.23001.30%
盘后:17.860.00000.00%16:15 EDT
成交量:82.07万
成交额:1,480.96万
市值:7.96亿
市盈率:-10.83
高:18.56
开:17.94
低:17.71
收:17.63
52周最高:32.71
52周最低:8.80
股本:4,456.17万
流通股本:2,651.52万
量比:0.80
换手率:3.10%
股息:- -
股息率:- -
每股收益(TTM):-1.6486
每股收益(LYR):-1.8100
净资产收益率:-26.16%
总资产收益率:-16.67%
市净率:3.10
市盈率(LYR):-9.87

数据加载中...

2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/21

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/21

重要事件披露

Form 8-K - Current report